about
Regulation of endothelial homeostasis, vascular development and angiogenesis by the transcription factor ERGClonal origin and spread of metastatic prostate cancerThe role of GATA2 in lethal prostate cancer aggressiveness.Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag.Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells.Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine.ETS transcription factor ETV2/ER71/Etsrp in hematopoietic and vascular development, injury, and regeneration.Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate CancerRNA splicing and splicing regulator changes in prostate cancer pathologyOvercoming Oncogenic Mediated Tumor Immunity in Prostate Cancer.BET bromodomain-mediated interaction between ERG and BRD4 promotes prostate cancer cell invasion.Nasal administration of interleukin-33 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma surrogate.Significance of the TMPRSS2:ERG gene fusion in prostate cancer.Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis.Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer.Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes.High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancerERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression.Expression analysis of cancer-testis genes in prostate cancer reveals candidates for immunotherapy.Expanding the effects of ERG on chromatin landscapes and dysregulated transcription in prostate cancer.Dynamic regulation of VEGF-inducible genes by an ERK/ERG/p300 transcriptional network.The molecular biology of prostate cancer: current understanding and clinical implications.MELODI: Mining Enriched Literature Objects to Derive Intermediates.Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance.Development of a computational promoter with highly efficient expression in tumors.The Role of Immunohistochemical Analysis as a Tool for the Diagnosis, Prognostic Evaluation and Treatment of Prostate Cancer: A Systematic Review of the LiteratureIntegrated Analysis of a Competing Endogenous RNA Network Revealing a Prognostic Signature for Cervical Cancer
P2860
Q26747155-BAE73495-6759-4621-A8B4-BAFB2B3A8349Q26752873-155489A3-CBD7-4988-83CC-A9F4B18A2E08Q33848134-480D445B-9481-4AAD-BFAF-90E5130E5D1BQ37635618-10C6B081-A6FE-4763-8A7F-4169D66B366AQ38729033-AA6DE247-61EA-4D06-98DE-8F2B33B0FC96Q39044222-42BCD323-1937-401D-BEE4-BA665F56F4D5Q39057795-594B1A2E-6671-45C3-8610-02184C824A05Q39164084-56481656-C5A3-4924-8982-C01652291A5DQ39223617-FB7BED02-2FB1-4F70-A816-CB961F55166DQ39438805-F06A3FE8-6B30-425E-A167-368756E48D75Q39737405-48F9D081-D663-4F90-B068-AD24A926BE14Q39871685-5851B177-AE0C-4287-8BE9-DF7588E6E970Q40067022-F35D753F-8EB8-4F9B-B133-5ED363023E2CQ41660235-239F406C-AF90-48BA-81CE-E6DF0A53E4D7Q42335698-158CDB10-739C-467A-A55E-042EB93E980EQ42371249-173AC281-7DAF-4418-A550-CCAE21E96CEFQ42539779-61DBB9B4-6EBD-4CFE-977F-513239B2B82DQ43269413-E058B294-AADD-4E3F-96F6-A5E4001A9B98Q47876991-5D3E5168-F98D-4CE7-9A2C-B68AFCAFD7E0Q47883924-8B075D81-B8B1-46C1-B0FD-8B7BD994C367Q48110740-AB8711F4-EBE7-4E2F-A11D-AA088E69259CQ49546811-5C2785F2-53DD-4847-B229-6A4E637BE018Q50000956-83EA6B74-C813-4839-9794-41F2B47E1EE5Q50251062-131C1046-4214-4596-AA2C-51347AA7C233Q52716170-BF33BFD6-1850-4614-83C6-FAE9DF5AB939Q57073785-13003AB1-F0BC-407D-A7E9-5DA701880795Q58761446-F22B6C9E-D1FD-42F2-9206-E4185F24A5E7
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The oncogene ERG: a key factor in prostate cancer.
@en
type
label
The oncogene ERG: a key factor in prostate cancer.
@en
prefLabel
The oncogene ERG: a key factor in prostate cancer.
@en
P2860
P356
P1433
P1476
The oncogene ERG: a key factor in prostate cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2015.109
P407
P577
2015-04-27T00:00:00Z
P6179
1020611968